Cutting edge: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells

Journal of Immunology

Volumn 173, Issue 11, 2004, Pages 6526-6531

  Huber, Samuel ^a   Schramm, Christoph ^a   Lehr, Hans A ^a   Mann, Amrit ^a   Schmitt, Steffen ^a   Becker, Christoph ^a   Protschka, Martina ^a   Galle, Peter R ^a   Neurath, Markus F ^a   Blessing, Manfred ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; DEXTRAN SULFATE; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; T LYMPHOCYTE; TRANSGENIC MOUSE; WILD TYPE;

EID: 9144219649     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.11.6526     Document Type: Article

References (29)

1. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693.
2. Diebold, R. J., M. J. Eis, M. Yin, I. Ormsby, G. P. Boivin, B. J. Darrow, J. E. Saffitz, and T. Doetschman. 1995. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA 92:12215.
3. Schramm, C., M. Protschka, H. Köhler, J. Podlech, M. J. Reddehase, P. Schirmacher, P. R. Galle, A. W. Lohse, and M. Blessing. 2003. Impairment of TGF-β signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am. J. Physiol. 284:G525.
4. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171.
5. Lucas, P. J., S. J. Kim, S. J. Melby, and R. E. Gress. 2000. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor βII receptor. J. Exp. Med. 191:1187.
6. Schramm, C., U. Herz, J. Podlech, M. Protschka, S. Finotto, M. J. Reddehase, H. Kohler, P. R. Galle, A. W. Lohse, and M. Blessing. 2003. TGF-β regulates airway responses via T cells. J. Immunol. 170:1313.
7. Schramm, C., J. Kriegsmann, M. Protschka, S. Huber, T. Hansen, E. Schmitt, P. R. Galle, and M. Blessing. 2004. Susceptibility to collagen-induced arthritis is modulated by TGFβ responsiveness of T cells. Arthritis Res. Ther. 6:R114.
8. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
9. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387.
10. - precursors in a thymus-independent process. J. Immunol. 172:923.
11. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198:1875.
12. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172:5149.
13. + regulatory T cells independent of autocrine TGF-β1. Blood 103:4594.
14. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
15. + T cells. J. Exp. Med. 183:2669.
16. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694.
17. Hartmann, G., C. Bidlingmaier, B. Siegmund, S. Albrich, J. Schulze, K. Tschoep, A. Eigler, H. A. Lehr, and S. Endres. 2000. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J. Pharmacol. Exp. Ther. 292:22.
18. + T cell pool and the expression of Foxp3 in vivo. Int. Immunol 16:1241.
19. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629.
20. + regulatory T cell activity in both humans and mice. J. Immunol. 172:834.
21. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 100:10878.
22. Suri-Payer, E., A. Z. Amar, R. McHugh, K. Natarajan, D. H. Margulies, and E. M. Shevach. 1999. Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur. J. Immunol. 29:669.
23. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.
24. Singh, B., S. Read, C. Asseman, V. Malmstrom, C. Mottet, L. A. Stephens, R. Stepankova, H. Tlaskalova, and F. Powrie. 2001. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182:190.
25. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111.
26. + regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J. Immunol. 171:5012.
27. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:237.
28. + regulatory T cells from human peripheral blood. J. Immunol. 166:7282.
29. + regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci USA 101:4572.